Just 4 days ahead of the Tour de France, news broke that Andre Cardoso from Trek-Segafredo tested positive for EPO.
The Portuguese rider was selected by the American team to start the Tour de France.
“The Union Cycliste Internationale (UCI) announces that Portuguese rider André Cardoso was notified of an Adverse Analytical Finding (AAF) of Erythropoietin in a sample collected in the scope of an out-of-competition control on 18 June 2017”, the UCI said in a statement.
“To our cycling family, we have some disappointing news to share”, Trek-Segafredo team announced in a statement.
“It is with deep disappointment that we have just learned that our rider, Andre Cardoso, has tested positive for a prohibited substance. In accordance with our zero tolerance policy, he has been suspended immediately.
“We hold our riders and staff to the highest ethical standards and will act and communicate accordingly as more details become available”.